close

Clinical Trials

1 218 219 220
Number of results: 4389

PDF print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2011-01-11 biosimilar rituximab rheumatoid arthritis 2 Sandoz (Switzerland) Autoimmune diseases – Inflammatory diseases - Rheumatic diseases
2011-01-10 BC-3781 acute bacterial skin and skin structure infections (ABSSSI) 2 Nabriva Therapeutics (Austria) Infectious diseases
2011-01-07 4SC-203 1 4SC (Germany) Cancer Oncology
2011-01-03 Nalmefene alcohol dependence 3 Lundbeck (Denmark) CNS diseases
2010-11-22 SYL040012 ocular hypertension., glaucoma 1-2 Sylentis (Spain) Ophtalmological diseases
2010-11-01 galunisertib (LY2157299) hepatocellular carcinoma 2 Eli Lilly (USA - IN) Cancer - Oncology
2010-10-12 galunisertib glioma 1b-2a Eli Lilly (USA - IN) Cancer - Oncology
2008-03-05 aglatimagene besadenovec (AdV-tk) followed by valacyclovir glioma 1 Advantagene (USA - MA) Cancer - Oncology
2007-12-27 aglatimagene besadenovec (AdV-tk) followed by valacyclovir glioma 2a Advantagene (USA - MA) Cancer - Oncology